Abstract
The risk of thromboembolism is increased in inflammatory bowel disease and its symptoms may be overlooked. Furthermore, its treatment can be complex and is not without complications. We describe a case of an adolescent boy who developed a cerebral sinus venous thrombosis during a relapse of his ulcerative colitis and who, while on treatment with heparin, developed heparin-induced thrombocytopenia (HIT). The treatment was then switched to fondaparinux, a synthetic and selective inhibitor of activated factor X.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adolescent
-
Colitis, Ulcerative / complications*
-
Fondaparinux
-
Heparin / adverse effects*
-
Heparin / therapeutic use*
-
Humans
-
Intracranial Thrombosis / drug therapy*
-
Intracranial Thrombosis / epidemiology
-
Male
-
Polysaccharides / therapeutic use
-
Risk Factors
-
Thrombocytopenia / chemically induced*
-
Thrombocytopenia / diagnosis
-
Venous Thrombosis / drug therapy*
-
Venous Thrombosis / epidemiology
Substances
-
Polysaccharides
-
Heparin
-
Fondaparinux